Parsippany-based Ferring Pharmaceuticals announced Wednesday it has named Sophie Opdyke as its new vice president, general manager, oncology, effective immediately.
Opdyke will be responsible for building Ferring’s U.S. division, heading its day-to-day operations and shaping its business plan.
Opdyke, who has more than 20 years of experience in the pharmaceutical industry, most recently served as vice president, immuno-oncology lead at Pfizer.
“We’re delighted to welcome Sophie as the leader of our new oncology division as we prepare for a significant expansion of our presence in this area,” Paul Navarre, CEO, Ferring Pharmaceuticals, said. “Sophie’s depth of oncology experience and expertise are a significant asset to our U.S. leadership team.”
